ºÝºÝߣshows by User: mrotily / http://www.slideshare.net/images/logo.gif ºÝºÝߣshows by User: mrotily / Sun, 21 Aug 2016 12:02:37 GMT ºÝºÝߣShare feed for ºÝºÝߣshows by User: mrotily ºÝºÝߣs Rotily Urgences Ehpad - Présentation https://fr.slideshare.net/slideshow/slides-rotily-urgences-ehpad-prsentation/65205042 slidesrotilyurgencesehpadspg041215final-160821120237
Prise en charge des résidents des maisons de retraite médicalisées (EHPAD) dans les services des services d'accueil des urgences; une enquête en région PACA]]>
Prise en charge des résidents des maisons de retraite médicalisées (EHPAD) dans les services des services d'accueil des urgences; une enquête en région PACA]]> Sun, 21 Aug 2016 12:02:37 GMT https://fr.slideshare.net/slideshow/slides-rotily-urgences-ehpad-prsentation/65205042 mrotily@slideshare.net(mrotily) ºÝºÝߣs Rotily Urgences Ehpad - Présentation mrotily Prise en charge des résidents des maisons de retraite médicalisées (EHPAD) dans les services des services d'accueil des urgences; une enquête en région PACA <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/slidesrotilyurgencesehpadspg041215final-160821120237-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Prise en charge des résidents des maisons de retraite médicalisées (EHPAD) dans les services des services d&#39;accueil des urgences; une enquête en région PACA
from Michel Rotily
]]> 259 5 https://cdn.slidesharecdn.com/ss_thumbnails/slidesrotilyurgencesehpadspg041215final-160821120237-thumbnail.jpg?width=120&height=120&fit=bounds presentation Black http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - ISPOR 2014, Amsterdam /slideshow/2014-1021-poster-ispor-mean-cost-pgi12-en-v10/41918857 2014-10-21posterispormeancostpgi-12env1-141123112342-conversion-gate02
MEAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - Poster ISPOR 2014, Amsterdam]]>
MEAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - Poster ISPOR 2014, Amsterdam]]> Sun, 23 Nov 2014 11:23:42 GMT /slideshow/2014-1021-poster-ispor-mean-cost-pgi12-en-v10/41918857 mrotily@slideshare.net(mrotily) M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - ISPOR 2014, Amsterdam mrotily MEAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - Poster ISPOR 2014, Amsterdam <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-21posterispormeancostpgi-12env1-141123112342-conversion-gate02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> MEAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - Poster ISPOR 2014, Amsterdam
M EAN ANNUAL COST OF PATIENTS HOSPITALIZED FOR CHRONIC HEPATITIS C IN F RANCE THE HEPC-LONE STUDY - ISPOR 2014, Amsterdam from Michel Rotily
]]> 280 5 https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-21posterispormeancostpgi-12env1-141123112342-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 B URDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012 - ISPOR 2014, Amsterdam /mrotily/2014-1022-poster-ispor-pgi11-v10 2014-10-22posterisporpgi-11v1-141123112051-conversion-gate02
BURDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012]]>
BURDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012]]> Sun, 23 Nov 2014 11:20:51 GMT /mrotily/2014-1022-poster-ispor-pgi11-v10 mrotily@slideshare.net(mrotily) B URDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012 - ISPOR 2014, Amsterdam mrotily BURDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-22posterisporpgi-11v1-141123112051-conversion-gate02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> BURDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012
B URDEN OF HOSPITALIZATIONS RELATED TO CHRONIC HEPATITIS C IN F RANCE Evolution between 2009 and 2012 - ISPOR 2014, Amsterdam from Michel Rotily
]]> 294 1 https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-22posterisporpgi-11v1-141123112051-conversion-gate02-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Poster 16th eccmid p596 1 hiv hbv vaccination 2006 /slideshow/poster-16th-eccmid-p596-1-hiv-hbv-vaccination-2006/13350797 poster16theccmidp596-1hivhbvvaccination2006-120616103809-phpapp02
Free Anonymous HIV Testing Sites are an opportunity to offer hepatitis B virus vaccination to high risk non immune patients]]>
Free Anonymous HIV Testing Sites are an opportunity to offer hepatitis B virus vaccination to high risk non immune patients]]> Sat, 16 Jun 2012 10:38:07 GMT /slideshow/poster-16th-eccmid-p596-1-hiv-hbv-vaccination-2006/13350797 mrotily@slideshare.net(mrotily) Poster 16th eccmid p596 1 hiv hbv vaccination 2006 mrotily Free Anonymous HIV Testing Sites are an opportunity to offer hepatitis B virus vaccination to high risk non immune patients <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/poster16theccmidp596-1hivhbvvaccination2006-120616103809-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Free Anonymous HIV Testing Sites are an opportunity to offer hepatitis B virus vaccination to high risk non immune patients
Poster 16th eccmid p596 1 hiv hbv vaccination 2006 from Michel Rotily
]]> 974 7 https://cdn.slidesharecdn.com/ss_thumbnails/poster16theccmidp596-1hivhbvvaccination2006-120616103809-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Repères épidémiologiques et économiques au moment de l'arrivée des nouvelles thérapies de l'hépatite C - M. Rotily https://fr.slideshare.net/slideshow/repres-pidmiologiques-et-conomiques-au-moment-de-larrive-des-nouvelles-thrapies-de-lhpatite-c-m-rotily/10819327 prsentationsympo171111final-120105085310-phpapp02
Repères épidémiologiques et économiques au moment de l'arrivée des nouvelles thérapies de l'hépatite C - M. Rotily - Toulouse - Novembre 2011]]>
Repères épidémiologiques et économiques au moment de l'arrivée des nouvelles thérapies de l'hépatite C - M. Rotily - Toulouse - Novembre 2011]]> Thu, 05 Jan 2012 08:53:09 GMT https://fr.slideshare.net/slideshow/repres-pidmiologiques-et-conomiques-au-moment-de-larrive-des-nouvelles-thrapies-de-lhpatite-c-m-rotily/10819327 mrotily@slideshare.net(mrotily) Repères épidémiologiques et économiques au moment de l'arrivée des nouvelles thérapies de l'hépatite C - M. Rotily mrotily Repères épidémiologiques et économiques au moment de l'arrivée des nouvelles thérapies de l'hépatite C - M. Rotily - Toulouse - Novembre 2011 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/prsentationsympo171111final-120105085310-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Repères épidémiologiques et économiques au moment de l&#39;arrivée des nouvelles thérapies de l&#39;hépatite C - M. Rotily - Toulouse - Novembre 2011
from Michel Rotily
]]> 727 14 https://cdn.slidesharecdn.com/ss_thumbnails/prsentationsympo171111final-120105085310-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) EASL 2007 /slideshow/sci-070359-cheobs-easl2007/9974132 sci-07-0359cheobseasl2007-111101050602-phpapp01
A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) by JP Lang, P Melin, D Ouzan, L Cattan, M Chousterman, M. Rotily, T Fontanges, P Marcellin, P Cacoub]]>
A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) by JP Lang, P Melin, D Ouzan, L Cattan, M Chousterman, M. Rotily, T Fontanges, P Marcellin, P Cacoub]]> Tue, 01 Nov 2011 05:06:00 GMT /slideshow/sci-070359-cheobs-easl2007/9974132 mrotily@slideshare.net(mrotily) A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) EASL 2007 mrotily A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) by JP Lang, P Melin, D Ouzan, L Cattan, M Chousterman, M. Rotily, T Fontanges, P Marcellin, P Cacoub <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/sci-07-0359cheobseasl2007-111101050602-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) by JP Lang, P Melin, D Ouzan, L Cattan, M Chousterman, M. Rotily, T Fontanges, P Marcellin, P Cacoub
A Prospective, Multicenter, Observational Study on Adherence With Viral Hepatitis C Treatments (CHEOBS Study): Impact of Past Psychiatric Disorders on Sustained Virologic Response (SVR) EASL 2007 from Michel Rotily
]]> 255 2 https://cdn.slidesharecdn.com/ss_thumbnails/sci-07-0359cheobseasl2007-111101050602-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Factors Related to HCV Screening in French General Practice /mrotily/rotily-gcb-2001 rotilygcb2001-111101050558-phpapp02
Factors Related to HCV Screening in French General Practice - Published in Gastroenterologie Clinique et Biologique 2001]]>
Factors Related to HCV Screening in French General Practice - Published in Gastroenterologie Clinique et Biologique 2001]]> Tue, 01 Nov 2011 05:05:55 GMT /mrotily/rotily-gcb-2001 mrotily@slideshare.net(mrotily) Factors Related to HCV Screening in French General Practice mrotily Factors Related to HCV Screening in French General Practice - Published in Gastroenterologie Clinique et Biologique 2001 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/rotilygcb2001-111101050558-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Factors Related to HCV Screening in French General Practice - Published in Gastroenterologie Clinique et Biologique 2001
Factors Related to HCV Screening in French General Practice from Michel Rotily
]]> 427 1 https://cdn.slidesharecdn.com/ss_thumbnails/rotilygcb2001-111101050558-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Patient education improves adherence to HCV therapy -the CHEOBS Study /slideshow/patient-education-improves-adherence-cheobs-world-j-gastro-2008/9974125 patienteducationimprovesadherencecheobsworldjgastro2008-111101050552-phpapp01
]]>
]]> Tue, 01 Nov 2011 05:05:50 GMT /slideshow/patient-education-improves-adherence-cheobs-world-j-gastro-2008/9974125 mrotily@slideshare.net(mrotily) Patient education improves adherence to HCV therapy -the CHEOBS Study mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/patienteducationimprovesadherencecheobsworldjgastro2008-111101050552-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Patient education improves adherence to HCV therapy -the CHEOBS Study from Michel Rotily
]]> 1566 2 https://cdn.slidesharecdn.com/ss_thumbnails/patienteducationimprovesadherencecheobsworldjgastro2008-111101050552-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study - CHEOBS Study /slideshow/marcellin-2011-liver-intnl-published-online/9974112 marcellin2011liverintnl-publishedonline-111101050526-phpapp01
Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study by Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet,Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group published in Liver Int 2011]]>
Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study by Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet,Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group published in Liver Int 2011]]> Tue, 01 Nov 2011 05:05:24 GMT /slideshow/marcellin-2011-liver-intnl-published-online/9974112 mrotily@slideshare.net(mrotily) Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study - CHEOBS Study mrotily Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study by Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet,Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group published in Liver Int 2011 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/marcellin2011liverintnl-publishedonline-111101050526-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study by Patrick Marcellin, Michel Chousterman, Thierry Fontanges, Denis Ouzan, Michel Rotily, Marina Varastet,Jean-Philippe Lang, Pascal Melin and Patrice Cacoub, for the CheObs Study Group published in Liver Int 2011
Adherence to treatment and quality of life during hepatitis C therapy:a prospective, real-life, observational study - CHEOBS Study from Michel Rotily
]]> 597 2 https://cdn.slidesharecdn.com/ss_thumbnails/marcellin2011liverintnl-publishedonline-111101050526-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Hiv testing in minorities and women 1999 /slideshow/hiv-testinge-kabp-minorities-and-women-jnca-1999/9974107 hivtestingekabpminoritiesandwomenjnca1999-111101050515-phpapp01
]]>
]]> Tue, 01 Nov 2011 05:05:13 GMT /slideshow/hiv-testinge-kabp-minorities-and-women-jnca-1999/9974107 mrotily@slideshare.net(mrotily) Hiv testing in minorities and women 1999 mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/hivtestingekabpminoritiesandwomenjnca1999-111101050515-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Hiv testing in minorities and women 1999 from Michel Rotily
]]> 348 3 https://cdn.slidesharecdn.com/ss_thumbnails/hivtestingekabpminoritiesandwomenjnca1999-111101050515-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis /mrotily/gp-halfon-chlamydia gphalfonchlamydia-111101050440-phpapp02
Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis by P. Halfon, N. Limal, G. Penaranda, H. Khiri, D. Sene ,M. Andreu, J.M. Feryn, M. Rotily, R. Serra,J.C. Piette, P. Cacoub in Journal of Infection 2005]]>
Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis by P. Halfon, N. Limal, G. Penaranda, H. Khiri, D. Sene ,M. Andreu, J.M. Feryn, M. Rotily, R. Serra,J.C. Piette, P. Cacoub in Journal of Infection 2005]]> Tue, 01 Nov 2011 05:04:38 GMT /mrotily/gp-halfon-chlamydia mrotily@slideshare.net(mrotily) Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis mrotily Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis by P. Halfon, N. Limal, G. Penaranda, H. Khiri, D. Sene ,M. Andreu, J.M. Feryn, M. Rotily, R. Serra,J.C. Piette, P. Cacoub in Journal of Infection 2005 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/gphalfonchlamydia-111101050440-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis by P. Halfon, N. Limal, G. Penaranda, H. Khiri, D. Sene ,M. Andreu, J.M. Feryn, M. Rotily, R. Serra,J.C. Piette, P. Cacoub in Journal of Infection 2005
Chronic Chlamydia pneumoniae infection inpatients with symptomatic atherothrombosis from Michel Rotily
]]> 565 5 https://cdn.slidesharecdn.com/ss_thumbnails/gphalfonchlamydia-111101050440-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000. https://fr.slideshare.net/slideshow/evaluation-ror-12-dpts-francais-ors-2000/9974094 evaluationror12dptsfrancaisors2000-111101050433-phpapp01
Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000 by ]]>
Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000 by ]]> Tue, 01 Nov 2011 05:04:32 GMT https://fr.slideshare.net/slideshow/evaluation-ror-12-dpts-francais-ors-2000/9974094 mrotily@slideshare.net(mrotily) Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000. mrotily Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000 by <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/evaluationror12dptsfrancaisors2000-111101050433-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Evaluation de la couverture vaccinale Rougeole-Oreillons-Rubéole dans 12 départements français en 2000 by
from Michel Rotily
]]> 1567 2 https://cdn.slidesharecdn.com/ss_thumbnails/evaluationror12dptsfrancaisors2000-111101050433-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Effects lapd or hfd urolithiasis kidney int 2000 /slideshow/effects-lapd-or-hfd-urolithiasis-kidney-int-2000/9974081 effectslapdorhfdurolithiasiskidneyint2000-111101050350-phpapp02
]]>
]]> Tue, 01 Nov 2011 05:03:48 GMT /slideshow/effects-lapd-or-hfd-urolithiasis-kidney-int-2000/9974081 mrotily@slideshare.net(mrotily) Effects lapd or hfd urolithiasis kidney int 2000 mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/effectslapdorhfdurolithiasiskidneyint2000-111101050350-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Effects lapd or hfd urolithiasis kidney int 2000 from Michel Rotily
]]> 437 3 https://cdn.slidesharecdn.com/ss_thumbnails/effectslapdorhfdurolithiasiskidneyint2000-111101050350-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Calcium intake is weakly negatively associated with iron status j nutr 1999 /slideshow/calcium-intake-is-weakly-negatively-associated-with-iron-status-j-nutr-1999/9974060 calciumintakeisweaklynegativelyassociatedwithironstatusjnutr1999-111101050247-phpapp01
]]>
]]> Tue, 01 Nov 2011 05:02:42 GMT /slideshow/calcium-intake-is-weakly-negatively-associated-with-iron-status-j-nutr-1999/9974060 mrotily@slideshare.net(mrotily) Calcium intake is weakly negatively associated with iron status j nutr 1999 mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/calciumintakeisweaklynegativelyassociatedwithironstatusjnutr1999-111101050247-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
Calcium intake is weakly negatively associated with iron status j nutr 1999 from Michel Rotily
]]> 334 2 https://cdn.slidesharecdn.com/ss_thumbnails/calciumintakeisweaklynegativelyassociatedwithironstatusjnutr1999-111101050247-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Barometre nutrition https://fr.slideshare.net/slideshow/barometre-nutrition/9974056 barometrenutrition-111101050240-phpapp01
]]>
]]> Tue, 01 Nov 2011 05:02:36 GMT https://fr.slideshare.net/slideshow/barometre-nutrition/9974056 mrotily@slideshare.net(mrotily) Barometre nutrition mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/barometrenutrition-111101050240-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
from Michel Rotily
]]> 514 2 https://cdn.slidesharecdn.com/ss_thumbnails/barometrenutrition-111101050240-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Rapport cadmium santé https://fr.slideshare.net/slideshow/01-r5-rapport-cadmium/9974053 01-r5rapportcadmium-111101050231-phpapp02
]]>
]]> Tue, 01 Nov 2011 05:02:30 GMT https://fr.slideshare.net/slideshow/01-r5-rapport-cadmium/9974053 mrotily@slideshare.net(mrotily) Rapport cadmium santé mrotily <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/01-r5rapportcadmium-111101050231-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br>
from Michel Rotily
]]> 1440 3 https://cdn.slidesharecdn.com/ss_thumbnails/01-r5rapportcadmium-111101050231-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Evaluation économique du dépistage et du traitement de l'hépatite C https://fr.slideshare.net/slideshow/medsci2002183p325/9974035 medsci2002183p325-111101050124-phpapp02
Evaluation économique du dépistage et du traitement de l'hépatite C, Med Sci 2002]]>
Evaluation économique du dépistage et du traitement de l'hépatite C, Med Sci 2002]]> Tue, 01 Nov 2011 05:01:23 GMT https://fr.slideshare.net/slideshow/medsci2002183p325/9974035 mrotily@slideshare.net(mrotily) Evaluation économique du dépistage et du traitement de l'hépatite C mrotily Evaluation économique du dépistage et du traitement de l'hépatite C, Med Sci 2002 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/medsci2002183p325-111101050124-phpapp02-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Evaluation économique du dépistage et du traitement de l&#39;hépatite C, Med Sci 2002
from Michel Rotily
]]> 1534 3 https://cdn.slidesharecdn.com/ss_thumbnails/medsci2002183p325-111101050124-phpapp02-thumbnail.jpg?width=120&height=120&fit=bounds document White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Profils socio-médicaux des personnes détenues sous traitement de substitution https://fr.slideshare.net/mrotily/profils-sociomdicaux-des-personnes-dtenues-sous-traitement-de-substitution atelier4vendredi26obradovic-110916102655-phpapp01
Profils socio-médicaux des personnes détenues sous traitement de substitution : Résultats de l’étude RECAMS-LINSEARCH by Ivana Obradovic (OFDT), Jean-Noël Marzo (RECAMS), Michel Rotily (Clinsearch) Présenté à THS 8, 26 octobre 2007]]>
Profils socio-médicaux des personnes détenues sous traitement de substitution : Résultats de l’étude RECAMS-LINSEARCH by Ivana Obradovic (OFDT), Jean-Noël Marzo (RECAMS), Michel Rotily (Clinsearch) Présenté à THS 8, 26 octobre 2007]]> Fri, 16 Sep 2011 10:26:53 GMT https://fr.slideshare.net/mrotily/profils-sociomdicaux-des-personnes-dtenues-sous-traitement-de-substitution mrotily@slideshare.net(mrotily) Profils socio-médicaux des personnes détenues sous traitement de substitution mrotily Profils socio-médicaux des personnes détenues sous traitement de substitution : Résultats de l’étude RECAMS-LINSEARCH by Ivana Obradovic (OFDT), Jean-Noël Marzo (RECAMS), Michel Rotily (Clinsearch) Présenté à THS 8, 26 octobre 2007 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/atelier4vendredi26obradovic-110916102655-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Profils socio-médicaux des personnes détenues sous traitement de substitution : Résultats de l’étude RECAMS-LINSEARCH by Ivana Obradovic (OFDT), Jean-Noël Marzo (RECAMS), Michel Rotily (Clinsearch) Présenté à THS 8, 26 octobre 2007
from Michel Rotily
]]> 448 3 https://cdn.slidesharecdn.com/ss_thumbnails/atelier4vendredi26obradovic-110916102655-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Ircams beh draft_1_070509 https://fr.slideshare.net/slideshow/ircams-beh-draft1070509/9285283 ircamsbehdraft1070509-110916102420-phpapp01
Traitement de substitution aux opiacés à l’entrée en milieu carcéral : résultats initiaux de l’étude prospective IRCAMS]]>
Traitement de substitution aux opiacés à l’entrée en milieu carcéral : résultats initiaux de l’étude prospective IRCAMS]]> Fri, 16 Sep 2011 10:24:18 GMT https://fr.slideshare.net/slideshow/ircams-beh-draft1070509/9285283 mrotily@slideshare.net(mrotily) Ircams beh draft_1_070509 mrotily Traitement de substitution aux opiacés à l’entrée en milieu carcéral : résultats initiaux de l’étude prospective IRCAMS <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/ircamsbehdraft1070509-110916102420-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Traitement de substitution aux opiacés à l’entrée en milieu carcéral : résultats initiaux de l’étude prospective IRCAMS
from Michel Rotily
]]> 371 1 https://cdn.slidesharecdn.com/ss_thumbnails/ircamsbehdraft1070509-110916102420-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds document 000000 http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? https://fr.slideshare.net/slideshow/orphan-drugs-9285163/9285163 biomsibiorezo250908orphandrugsfinal-110916101518-phpapp01
Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? Présentation donnée dans le cadre du BioRezo et Euroboméditérannée à Sophia-Antipolis en 2009]]>
Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? Présentation donnée dans le cadre du BioRezo et Euroboméditérannée à Sophia-Antipolis en 2009]]> Fri, 16 Sep 2011 10:15:15 GMT https://fr.slideshare.net/slideshow/orphan-drugs-9285163/9285163 mrotily@slideshare.net(mrotily) Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? mrotily Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? Présentation donnée dans le cadre du BioRezo et Euroboméditérannée à Sophia-Antipolis en 2009 <img style="border:1px solid #C3E6D8;float:right;" alt="" src="https://cdn.slidesharecdn.com/ss_thumbnails/biomsibiorezo250908orphandrugsfinal-110916101518-phpapp01-thumbnail.jpg?width=120&amp;height=120&amp;fit=bounds" /><br> Orphan drugs - Le statut Orphan Drug: Une stratégie pour accélérer le développement de tout nouveau médicament? Présentation donnée dans le cadre du BioRezo et Euroboméditérannée à Sophia-Antipolis en 2009
from Michel Rotily
]]> 1661 292 https://cdn.slidesharecdn.com/ss_thumbnails/biomsibiorezo250908orphandrugsfinal-110916101518-phpapp01-thumbnail.jpg?width=120&height=120&fit=bounds presentation White http://activitystrea.ms/schema/1.0/post http://activitystrea.ms/schema/1.0/posted 0 https://cdn.slidesharecdn.com/profile-photo-mrotily-48x48.jpg?cb=1583344334 Epidemiology (MD, PhD) - Epidemiology and Pharmacoepidemiology, especially in ageing research and evaluation - Health Outcome Research - Drug Utilization Research - Pharmacoeconomics - Research and project strategy, design, data analysis and medical writing - Medical, pharmaceutical and health technology review My objectives: To establish partnership with health services/research units/agencies/companies involved in health assessment (drug utilization, access to health care and screening programmes, epidemiological registries and observatories, HOR and PROs) Specializations : Therapeutic Areas: - Geriatrics - Addictions and viral hepatitis - Gastroenterology and nutrition Services pro... www.pharmacoepidemiology-consultant.com/ https://cdn.slidesharecdn.com/ss_thumbnails/slidesrotilyurgencesehpadspg041215final-160821120237-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/slides-rotily-urgences-ehpad-prsentation/65205042 ºÝºÝߣs Rotily Urgences... https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-21posterispormeancostpgi-12env1-141123112342-conversion-gate02-thumbnail.jpg?width=320&height=320&fit=bounds slideshow/2014-1021-poster-ispor-mean-cost-pgi12-en-v10/41918857 M EAN ANNUAL COST OF P... https://cdn.slidesharecdn.com/ss_thumbnails/2014-10-22posterisporpgi-11v1-141123112051-conversion-gate02-thumbnail.jpg?width=320&height=320&fit=bounds mrotily/2014-1022-poster-ispor-pgi11-v10 B URDEN OF HOSPITALIZA...